EUVIMEDEUVIMED entdecken
Crossref

Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri

Javad Fathi, Jafar Amani, Shahram Nazarian, Nahal Hadi, Seyed Ali Mirhosseini, Reza Ranjbar, Hossein Samiei Abianeh

Microbial Pathogenesis · 2023

DOI: 10.1016/j.micpath.2023.106066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2023. Verfasst von Javad Fathi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic…. Hauptthemen laut MEDLINE: Escherichia coli, Dysentery, Bacillary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Baqiyatallah University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDS: Shigella spp. causes bloody diarrhea and leads to death, especially in children. Chimeric proteins containing virulence factors can prevent Shigella infection. The purpose of this study is to investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens against shiga toxin, S. dysenteri and S. flexneri in vitro and in vivo conditions. METHODS: Recombinant vector was transferred to E. coli BL21. The expression of the chimeric protein was confirmed by SDS PAGE and purified using the Ni-NTA column. Mice were immunized with recombinant protein and antibody titer was evaluated by ELISA. 10, 25 and 50 LD50 of Shiga toxin neutralization was evaluated in vitro (Vero cell line) and in vivo conditions. Also, the challenge of immunized mice with 10, 25 and 50 LD50 of S. dysentery and S. flexneri was done. RESULTS: The expression and purification of the recombinant protein with 60.6 kDa was done. ELISA showed increased antibody titer against the chimeric protein. MTT assay indicated that 1/8000 dilution of the sera had a 51% of cell viability against the toxin in Vero cell line. The challenge of mice immunized with toxin showed that the mice had complete protection against 10 and 25 LD50 of toxin and had 40% survival against 50 LD50. Mice receiving 10 and 25 LD50 of S. dysenteri and S. flexneri had 100% protection and in 50 LD50 the survival rate was 60 and 50%, respectively. Organ burden showed that the amount of bacterial colonization in immunized mice was 1 × 104 CFU/mL, which was significantly different from the control group. CONCLUSION: This study showed that chimeric proteins can create favorable immunogenicity in the host as vaccine candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliDysentery, BacillaryAnimalsMiceAntigens, BacterialBacterial VaccinesRecombinant ProteinsShiga ToxinsRecombinant Fusion ProteinsAntibodies, BacterialShigella flexneriMice, Inbred BALB C

Stichwörter der Autor:innen

IpaDRecombinant proteinShigella sppStxB and TolCVaccine candidate

Substanzen

Antigens, BacterialBacterial VaccinesRecombinant ProteinsShiga ToxinsRecombinant Fusion ProteinsAntibodies, Bacterial

Autor:innen und Institutionen

  • Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: javadfathi70@yahoo.com.
  • Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: jafar.amani@gmail.com.
  • Department of Biological Sciences, Faculty of Science, Imam Hossein University, Tehran, Iran. Electronic address: kpnazari@ihu.ac.ir.
  • Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Förderung

  • Baqiyatallah University of Medical Sciences

Zitieren

APA

Fathi, J., Amani, J., Nazarian, S., Hadi, N., Mirhosseini, S. A., Ranjbar, R., & Abianeh, H. S. (2023). Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2023.106066

Vancouver

Fathi J, Amani J, Nazarian S, Hadi N, Mirhosseini SA, Ranjbar R, et al. Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri. Microbial Pathogenesis. 2023. doi:10.1016/j.micpath.2023.106066

BibTeX
@article{Fathi2023,
  author = {Fathi, Javad and Amani, Jafar and Nazarian, Shahram and Hadi, Nahal and Mirhosseini, Seyed Ali and Ranjbar, Reza and Abianeh, Hossein Samiei},
  title = {Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri},
  journal = {Microbial Pathogenesis},
  year = {2023},
  doi = {10.1016/j.micpath.2023.106066}
}
Kostenlos starten →